Literature DB >> 21298312

Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis.

Yoshiki Tsuchiya1, Yoshifumi Ubara2, Tatsuya Suwabe2, Junichi Hoshino2, Keiichi Sumida2, Rikako Hiramatsu2, Eiko Hasegawa2, Masayuki Yamanouchi2, Noriko Hayami2, Yuji Marui2, Naoki Sawa2, Fumi Takemoto2, Kenmei Takaichi2.   

Abstract

Acute promyelocytic leukemia (APL) has the best prognosis among acute leukemias, but there is little data about APL in patients on hemodialysis. A 64-year-old hemodialysis patient was successfully treated for APL by induction therapy with all-trans retinoic acid (ATRA), three courses of consolidation therapy with Ara-C, mitomycin C (MIT), daunorubicin (DNR), and idarubicin (IDR), and maintenance therapy with ATRA. Complete remission has been maintained for 42 months in this patient. With dose modification, ATRA and chemotherapy may be safely given to patients on hemodialysis.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21298312     DOI： 10.1007/s10157-011-0405-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


  12 in total

1.  Pharmacokinetics of a standard dose of cytarabine in a patient with acute promyelocytic leukemia undergoing continuous ambulatory peritoneal dialysis.

Authors:  Makoto Takeuchi; Takahiro Yamauchi; Isao Yoshida; Ryo Soda; Takanori Ueda; Kiyoshi Takahashi
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

2.  Pharmacokinetics of all-trans retinoic acid in acute promyelocytic leukemia patients on dialysis.

Authors:  Kimitaka Takitani; Koichi Nagai; Eiki Kanbe; Akiko Inoue; Chihiro Kawakami; Tomoko Kuno; Hiroshi Tamai
Journal:  Am J Hematol       Date:  2003-10       Impact factor: 10.047

3.  Arsenic trioxide in a hemodialytic patient with acute promyelocytic leukemia.

Authors:  Yuko Yamamoto; Makoto Sasaki; Kazuo Oshimi; Koichi Sugimoto
Journal:  Acta Haematol       Date:  2009-10-07       Impact factor: 2.195

4.  Annexin II and bleeding in acute promyelocytic leukemia.

Authors:  J S Menell; G M Cesarman; A T Jacovina; M A McLaughlin; E A Lev; K A Hajjar
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

5.  A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study.

Authors:  Norio Asou; Yuji Kishimoto; Hitoshi Kiyoi; Masaya Okada; Yasukazu Kawai; Motohiro Tsuzuki; Kentaro Horikawa; Mitsuhiro Matsuda; Katsuji Shinagawa; Tohru Kobayashi; Shigeki Ohtake; Miki Nishimura; Masatomo Takahashi; Fumiharu Yagasaki; Akihiro Takeshita; Yukihiko Kimura; Masako Iwanaga; Tomoki Naoe; Ryuzo Ohno
Journal:  Blood       Date:  2007-03-20       Impact factor: 22.113

6.  Effect of dialysis on all trans retinoic acid levels in a child with acute promyelocytic leukemia and renal failure.

Authors:  Madhvi Rajpurkar; Patricia Alcasabas; Indulekha Warrier; Rudolph P Valentini; Nancy Fassinger; Daniel A C Frattarelli; Yaddanapudi Ravindranath
Journal:  Pediatr Blood Cancer       Date:  2007-12       Impact factor: 3.167

7.  Successful treatment by all-trans retinoic acid in a patient with acute promyelocytic leukemia complicated by liver cirrhosis and polycystic kidney.

Authors:  Arito Yamane; Norifumi Tsukamoto; Takayuki Saitoh; Hideki Uchiumi; Hiroshi Handa; Masamitsu Karasawa; Yoshihisa Nojima; Hirokazu Murakami
Journal:  Intern Med       Date:  2009-09-15       Impact factor: 1.271

8.  AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity.

Authors:  L H Lindner; H Ostermann; W Hiddemann; A Kiani; M Würfel; T Illmer; C Karsch; U Platzbecker; G Ehninger; E Schleyer
Journal:  Int J Hematol       Date:  2008-10-04       Impact factor: 2.490

9.  Vitamin A toxicity and hypercalcaemia in chronic renal failure.

Authors:  K Farrington; P Miller; Z Varghese; R A Baillod; J F Moorhead
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-20

10.  Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function.

Authors:  M D'Incalci; C Rossi; M Zucchetti; R Urso; F Cavalli; C Mangioni; Y Willems; C Sessa
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701
View more
  3 in total

1.  Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells.

Authors:  Hui Hui; Xiaoxiao Zhang; Hui Li; Xiao Liu; Le Shen; Yu Zhu; Jingyan Xu; Qinglong Guo; Na Lu
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-16       Impact factor: 4.553

2.  Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide.

Authors:  Akiko Hashimoto; Yasuhiro Tanaka; Isaku Shinzato
Journal:  Clin Case Rep       Date:  2021-07-23

3.  Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide.

Authors:  Akiko Hashimoto; Yasuhiro Tanaka; Takayuki Ishikawa; Isaku Shinzato
Journal:  Clin Case Rep       Date:  2021-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.